Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1423-2022Class III

Soluble Transferrin Receptors Calibrator Series (STFR CAL), Catalog Number TF10161. IVD

Randox Laboratories, Limited / initiated 2022-06-09 / Terminated / root cause: manufacturing process

Randox Laboratories Ltd. began a recall of Soluble Transferrin Receptors Calibrator Series (STFR CAL), Catalog Number TF10161. IVD on . FDA classified it as Class III and gives the reason as "A customer reported a problem with the reagent and calibrator. Randox Laboratories carried out an investigation and confirmed the issue. The complaint is pertaining to atypical calibration curves that can results in...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1423-2022
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Randox Laboratories, Limited
Product
Soluble Transferrin Receptors Calibrator Series (STFR CAL), Catalog Number TF10161. IVD
Product code
DDG Transferrin, Antigen, Antiserum, Control
Reason for recall
A customer reported a problem with the reagent and calibrator. Randox Laboratories carried out an investigation and confirmed the issue. The complaint is pertaining to atypical calibration curves that can results in non-numerical results. This affects Siemens Atellica CH analysers only. Customer have reported an atypical calibration curve that results in the values around the low QC range to produce a non-numerical result. It appears to be related to the bottle values of the calibrator producing a curve shape that is too linear for the logitlog calculation to calculate. This issue can only be identified in the Atellica graphical view of the calibration. In most of the cases when this has occurred, it is picked up by the QC generating a Math Error, however, there are reports of QC shifts after calibration without the Math Error flagged that may be related to this issue. Results reported with STFR Level 1, with a concentration less than 1.7mg/L, using TF10159 and TF10161 can be underestimated by up to 30%. This issue has been reported with reagent lots 575475 and 562691, calibrator lots 537725 and 562696. No other complaints received.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
On June 9, 2022, the firm notified customers of the recall via email. The issue only affects Siemens Atellica CH analyzer users. No action is required if the assay is being run on other platforms. The issue will be resolved in Atellica Solution Software (SW) version 1.25.3. Until all Atellica CH analyzers in the laboratory are updated to SW 1.25.3, the assay can be run by Open Channel. Please contact [email protected] for an Atellica CH Open Channel application sheet. If the assay is not run by Open Channel prior to installation of SW version 1.25.3, the assay must be re-calibrated once 1.25.3 is installed. Customers were instructed to review results generated with the affected batches in line with the clinical profile of the patient.
Quantity in commerce
12 kits (US)
Distribution
US Nationwide distribution in the state of IL.
Product codes and lots
UDI-DI (GTIN): 05055273215557 All lots within expiry

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1423-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1422-2022Class IIITerminatedVoluntary: Firm initiated
Z-1423-2022Class IIITerminatedVoluntary: Firm initiated